newatlas.com

It was just a year ago that we first encountered a multitool which sported a tiny adjustable wrench. Well, the Orioners Z3 is the latest tool to also boast one of those, along with eight other handy features including a fold-out cutting blade.

No, this isn't the return of Marvel's Iron Man; Commonwealth Fusion Systems (CFS) has announced plans to build the world's first grid-scale fusion power plant near Richmond, Virginia.

As Saudi Arabia continues to reshape its desert landscape with an incredible number of ambitious construction projects, it has employed some high-tech robotic help to increase efficiency and speed things up.

It's easy to assume that the only thing a cute little squirrel poses a threat to is a nut, but it turns out they could have more of a murderous streak than we realized. After watching squirrels in California for 12 years, a team of scientists has ...

Sanctuary AI's Phoenix robot is certainly an impressive beast, with hydraulically actuated hands that are incredibly dextrous. Well, those hands have recently become even more useful, as each one is now capable of simultaneously holding and ...

After revealing a show-stopping concept version last year, Honda has announced it'll launch the 6th generation of its legendary Prelude sports coupe in late 2025.

BAE Systems has announced that STRIX, a new type of VTOL (vertical takeoff and landing) aircraft, made its first flight in late October. The flight was reportedly successful, paving the way for production of the unique aircraft.

Astronomers have discovered an exoplanet with a tail, like a gigantic comet. The planet, known as WASP-69b, is slowly evaporating in the radiation of its host star.

New research has found that a chemical abundant in fruits, vegetables and plant products can suppress the immune response seen in food allergies. It paves the way to developing a natural treatment for this globally increasing problem.

Hugely promising cancer drug dostarlimab is one step closer to being widely available, after the Food and Drug Administration granted it Breakthrough Therapy Designation status that, if successful, will expedite its path to market.